Clinical significance of hepatitis B virus mutants;Klinische bedeutung von hepatitis-B-virus-mutanten

Praxis

Volumn 87, Issue 6, 1998, Pages 205-209

  Moradpour, D ^a   Blum, H E ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Hepatitis B virus; Quasispecies; Variants mutants

Indexed keywords

FAMCICLOVIR; HEPATITIS B CORE ANTIBODY; HEPATITIS B VACCINE; HEPATITIS B(E) ANTIBODY; HEPATITIS B(E) ANTIGEN; LAMIVUDINE;

ACTIVE IMMUNIZATION; ANTIBODY RESPONSE; ANTIVIRAL ACTIVITY; DRUG EFFICACY; HEPATITIS B; HUMAN; PERSISTENT VIRUS INFECTION; SHORT SURVEY; TREATMENT FAILURE; TREATMENT PLANNING; VIRUS GENE; VIRUS MUTATION;

DISEASE PROGRESSION; HEPATITIS B; HEPATITIS B ANTIGENS; HEPATITIS B VIRUS; HUMANS; MUTATION; PROGNOSIS;

EID: 0032481416     PISSN: 16618157     EISSN: 16618165     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (8)

1. Fourei G., Tiollais P.: Molecular biology of hepatitis B virus. In: Bréchot C., ed. Primary liver cancer: etiological and progression factors. Boca Raton: CRC Press, 1994: 89-123.
2. Carman W., Thomas H., Domingo E.: Viral genetic variation: hepatitis B virus as a clinical example. Lancet 1993; 341: 349-353.
3. Nowak M.A., Bonhoeffer S., Hill A.M., Boehme R., Thomas H.C., McDade H.: Viral dynamics in hepatitis B virus infection. Proc Natl Acad Sci USA 1996; 93: 4398-4402.
4. Blum H.E.: Variants of hepatitis B. C and D viruses: molecular biology and clinical significance. Digestion 1995; 56: 85-95.
5. Chisuri F.V., Ferrari C.; Hepatitis B virus immunopathogenesis. Annu Rev Immunol 1995; 13: 29-60.
6. Bartholomew M.M., Janscn R.W., Jeffers L.J., Reddy K.R., Johnson L.C., Bunzendahl H., Condreay L.D., Tzakis A.G., Schiff E.R., Brown N.A.: Hepatitis B virus resistance to lamivudine given for recurrent infection after orthotopic liver transplantation. Lancet 1997; 349: 20-22.
7. Pult I., Chouard T., Wieland S., Klemenz R., Yaniv M., Blum H.E.: A hepatitis B virus mutant with a new hepatocyte nuclear factor binding site emerging in transplant transmitted fulminant hepatitis B. Hepatology 1997; 25: 1507-1515.
8. Bertoletli A., Sette A.. Chisari F.V., Penna A., Levrero M., De Carli M., Fiaccadori F., Ferrari C.: Natural variants of cytotoxic epitopes are T-cell receptor antagonists for antiviral cytotoxic T cells. Nature 1994; 369: 407-410.